Prevalence of metabolic syndrome among adults in sub-district hospital Akhnoor: a cross sectional study
DOI:
https://doi.org/10.18203/2349-3933.ijam20205000Keywords:
MetS, Hypertension, Diabetes mellitusAbstract
Background: Metabolic syndrome (MetS) is an aggregation of conditions that together increase the risk of cardiovascular disease in individuals, which would not otherwise be recognized. World-wide, its prevalence has been documented as 11-41%. It has become a major public health challenge globally due to rapid urbanization, sedentary lifestyle, and surplus energy intake.
Methods: The present hospital-based-study was aimed at finding the prevalence of MetS in people attending OPD of medicine in sub-district hospital Akhnoor, Jammu: from November 2019 to April 2020. Study subjects included both males and females between the age group of 20-60 years attending the medicine OPD. Among the 400 participants, 185 were females and 215 were males. Patients were diagnosed as MetS according to national cholesterol education program adult treatment panel-III (ATP) criteria.
Results: About 41.25% of the participants were below 40 years and 58.75% of the participants were above 40 years of age. A very high prevalence of 68.75% MetS was reported among patients, hinting at the changing lifestyle of the people. People of older age and with general obesity are under increased MetS risk. Prevalence among males (67.44%) and females (70.27%) differed only slightly. But our present study tends to suggest an increased risk among females, which is quite significant.
Conclusions: Various researchers have associated MetS with depression and chronic diseases, which shows that the population is under graver risk with increased prevalence among masses. The prevalence in >40 years age group is showing rapid and alarming increase. Lifestyle modifications are crucial to the management of MetS.
References
Nolan PB, Carrickranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Prev Med Rep. 2017;7:211-5.
Huang PL. A comprehensive definition for metabolic syndrome. Dis model Mech. 2009;2(5-6):231-7.
Borch-Johnsen K. The metabolic syndrome in a global perspective. The public health impact–secondary publication. Dan Med Bull. 2007;54:157-9.
Neill S, O Driscoll L. Metabolic syndrome a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1-12.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:1-21.
Basak A. Development of rapid and inexpensive plasma glucose estimation by two point kinetics method based on glucose-oxidase-peroidase enzymes. Indian J Clin Biochem. 2007;22(1):156-66.
Talke H, Schubert GE. Enymatische Harnstoff best immung in blut und serum in optichen test nach Warburg. klin wschr. 1965;41:174.
Knapp M, Mayne PD. Development of an automated kinetic jaffe method designed to minimize bilirubin interference in plasma creatinine assays. Clin Chim Acta. 1987;168:239-46.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. 2002;106(25):3143-421.
Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(1):s9-30.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med. 2003;163:36-42.
Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3:204-11.
Annani-Akollor ME, Laing EF, Osei H, Mehsah E. Prevalene of metabolic syndrome and the comparison of fasting plasma glucose and HbA1c as the glycemic criterion for MetS definition in non-diabetic population in Ghana. Diabetol Metab Sundr. 2019;11:26.
Agarwal A, Agarwal M. Metabolic Syndrome and central obesity in depression: A cross sectional study. Indian J Psychiatry. 2016;5821-6.
Acharyya A. Association of metabolic syndrome with chronic obstructive pulmonary disease in an Indian Population. Lung India. 2016;33:385-90.
